It remains to be determined whether the differential requirements for p110δ and p110α in suppressing anti-tumor responses versus autoimmunity are due to different thresholds of PI3K activity required under these distinct pathophysiological processes or whether there are CNS- or inflammation-specific factors that favor a role for p110α in EAE and spontaneous neuropathy. The gene discussed is PIK3CD; the disease is neoplasm.